Similar articles

• Chronic inflammation and CD16+ natural killer cell zeta-chain downregulation in hemodialysis patients.

  Eleftheriadis T, Kartsios C, Yiannaki E, Kazila P, Antoniadi G, Liakopoulos V, Markala D. Eleftheriadis T, et al. Blood Purif. 2008;26(4):317-21. doi: 10.1159/000130068. Epub 2008 May 8. Blood Purif. 2008. PMID: 18463433
• Decreased CD3+CD16+ natural killer-like T-cell percentage and zeta-chain expression accompany chronic inflammation in haemodialysis patients.

  Eleftheriadis T, Kartsios C, Yiannaki E, Antoniadi G, Kazila P, Pliakos K, Liakopoulos V, Markala D. Eleftheriadis T, et al. Nephrology (Carlton). 2009 Aug;14(5):471-5. doi: 10.1111/j.1440-1797.2008.01041.x. Epub 2009 Mar 26. Nephrology (Carlton). 2009. PMID: 19486472
• [Normal natural killer activity (NK-activity) in patients on a chronic dialysis program].

  Písa P, Jíra M, Horký J, Strejcek J. Písa P, et al. Cas Lek Cesk. 1986 Apr 25;125(17):527-30. Cas Lek Cesk. 1986. PMID: 3719629 Czech. No abstract available.
• Disturbances of acquired immunity in hemodialysis patients.

  Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I. Eleftheriadis T, et al. Semin Dial. 2007 Sep-Oct;20(5):440-51. doi: 10.1111/j.1525-139X.2007.00283.x. Semin Dial. 2007. PMID: 17897251 Review.
• Immune system dysregulation in uremia.

  Descamps-Latscha B, Herbelin A, Nguyen AT, Zingraff J, Jungers P, Chatenoud L. Descamps-Latscha B, et al. Semin Nephrol. 1994 May;14(3):253-60. Semin Nephrol. 1994. PMID: 8036360 Review. No abstract available.